Company Search:
Advanced Search
Sponsored Links
Morishita Jintan Co., Ltd. Company Snapshot
Morishita Jintan Co., Ltd. operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Morishita Jintan Co., Ltd. with three other companies in this sector in JAPAN : Linical Company Limited (2020 sales of 10.94 billion Japanese Yen [US$104.43 million] of which 91% was Cro Business), Shin Nippon Biomedical Laboratories Ltd (14.56 billion Japanese Yen [US$139.06 million] of which 90% was Pre-Clinical Business), and Japan Tissue Engineering Company Limited (2.31 billion Japanese Yen [US$22.06 million] of which 59% was Regenerative Medicine Products Business).

Sales Analysis. Morishita Jintan Co., Ltd. reported sales of ¥9.77 billion (US$93.34 million) for the fiscal year ending March of 2020. This represents a decrease of 3.1% versus 2019, when the company's sales were ¥10.09 billion. The sales level in 2020 was fairly close to the level five years ago: in 2015, Morishita Jintan Co., Ltd. had sales of ¥9.82 billion. Contributing to the drop in overall sales was the 7.3% decline in Capsule Contract Business, from ¥2.58 billion to ¥2.39 billion. There were also decreases in sales in Healthcare Business (down 2.6% to ¥7.30 billion) . However, these declines were partially offset by the increase in sales of Other (up 722.2% to ¥74.00 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Morishita Jintan Co., Ltd.
  Stock Performance Chart for Morishita Jintan Co., Ltd.
  Stock Data: Recent Stock Performance:
  Current Price (10/23/2020): 1,972.00
(Figures in Japanese Yen )
1 Week 0.1%   13 Weeks -1.5%  
4 Weeks 3.4%   52 Weeks -3.3%  
Morishita Jintan Co., Ltd. Key Data:
  Ticker: 4524 Country: Japan
  Exchanges: TYO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 9,774,000,000
(Year Ending Jan 2021).
Employees: 306
  Currency: Japanese Yen Market Cap: 8,028,025,804
  Fiscal Yr Ends: March Shares Outstanding: 4,071,007
  Share Type: Common Closely Held Shares: 1,931,530
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.